Ekso bionics holdings, inc. (EKSO)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Mar'13Dec'12
Revenue

13,917

11,332

7,353

-

-

-

-

-

-

Device and related

-

-

-

13,434

4,352

2,924

1,612

-

566

Engineering services

-

-

-

787

4,309

2,403

1,690

-

2,140

Total revenue

-

-

-

14,221

8,661

5,327

3,302

-

2,706

Device and related

-

-

-

10,715

3,926

2,048

1,461

-

553

Engineering services

-

-

-

559

3,556

1,720

1,254

-

1,783

Cost of revenue

7,153

7,023

5,284

11,274

7,482

3,768

2,715

-

2,336

Gross profit

6,764

4,309

2,069

2,947

1,179

1,559

587

-

370

REVENUES

-

-

-

-

-

-

-

0

-

Operating expenses:
Professional Fees

-

-

-

-

-

-

-

10

-

Sales and marketing

11,398

13,827

13,156

10,997

9,258

7,085

4,291

-

5,926

Research and development

4,596

5,847

9,483

8,879

6,480

3,868

2,677

-

4,304

Selling, General and Administrative Expense

-

-

-

-

-

-

-

1

-

General and administrative

7,409

11,665

10,715

10,853

7,002

7,400

3,913

-

4,381

Restructuring

-

-

659

0

0

-

-

-

-

Change in fair value, contingent consideration

-

-

332

196

0

-

-

-

-

Change in fair value, contingent consideration

-

-

-

-

-

0

-

-

-

Total operating expenses

23,403

31,339

33,681

30,533

22,740

18,353

10,881

12

14,611

Loss from operations

-16,639

-27,030

-31,612

-27,586

-21,561

-16,794

-10,294

-12

-14,241

Other income (expense), net:
Interest expense

384

600

648

16

13

435

1,726

-

736

Finance cost associated with warrant issuance

1,096

0

-

0

487

0

0

-

-

Gain (loss) on revaluation of warrant liabilities

6,376

1,063

3,909

4,286

2,505

-16,485

186

-

-

Loss on modification of warrant

-257

0

-

-

-

-

-

-

-

Gain (loss) on warrant liability

-

-

-

-

-

-

-

-

-17

Loss on repurchase of warrants

-

-

-1,067

0

0

-

-

-

-

Interest income

-

-

-

12

11

6

5

-

11

Total other income (expense), net

-132

-425

296

-166

-45

-16,975

-1,593

-

-801

Total other income, net

4,507

38

2,490

4,116

1,971

-61

-58

-

-93

PROVISION FOR INCOME TAXES

-

-

-

-

-

-

-

0

-

Net loss

-12,132

-26,992

-29,122

-23,470

-19,590

-33,769

-11,887

-12

-15,042

Less: Preferred deemed dividend

-

-

-

10,345

4,655

0

0

-

-

Net loss applicable to common shareholders

-

-

-

-33,815

-24,245

-33,769

-11,887

-

-

Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

142

248

-419

80

-1

0

-

-

-

Comprehensive loss

-11,990

-26,744

-29,541

-33,735

-24,246

-33,769

-

-

-

Basic and diluted net loss per share applicable to common shareholders (in dollars per share)

-0.17

-0.44

-0.82

-

-

-

-

0.00

-0.75

Earnings Per Share, Basic

-

-

-

-1.87

-1.66

-3.02

-0.57

-

-

Earnings Per Share, Diluted

-

-

-

-2.05

-1.83

-3.02

-0.57

-

-

Weighted Average Number of Shares Outstanding, Basic

-

-

-

18,126

14,606

11,181

20,977

-

-

Weighted Average Number of Shares Outstanding, Diluted

-

-

-

18,622

14,609

11,181

20,977

-

-

Weighted average number of shares outstanding, basic and diluted (in shares)

71,911

61,229

35,609

-

-

-

-

-

20,167